olmesartan has been researched along with reserpine in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (reserpine) | Trials (reserpine) | Recent Studies (post-2010) (reserpine) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 15,546 | 223 | 436 |
| Protein | Taxonomy | olmesartan (IC50) | reserpine (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.7875 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.2092 | |
| Quinolone resistance protein NorA | Staphylococcus aureus | 8.5429 | |
| Mu-type opioid receptor | Homo sapiens (human) | 4.152 | |
| Chromaffin granule amine transporter | Homo sapiens (human) | 0.05 | |
| Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | 0.0034 | |
| Synaptic vesicular amine transporter | Homo sapiens (human) | 0.0147 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Hayden, MR; Hitomi, H; Ichimura, A; Ito, S; Kaifu, K; Kawachi, H; Kiyomoto, H; Kobori, H; Kohno, M; Matsumoto, S; Nishijima, Y; Nishiyama, A; Ohsaki, H; Sofue, T; Sowers, JR; Urushihara, M; Whaley-Connell, A | 1 |
1 other study(ies) available for olmesartan and reserpine
| Article | Year |
|---|---|
Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydralazine; Hydrochlorothiazide; Imidazoles; Juxtaglomerular Apparatus; Male; Membrane Proteins; Podocytes; Rats; Rats, Inbred OLETF; Reserpine; Tetrazoles | 2012 |